These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 16102751

  • 1. Genetic background determines susceptibility to experimental immune-mediated blepharoconjunctivitis: comparison of Balb/c and C57BL/6 mice.
    Fukushima A, Yamaguchi T, Ishida W, Fukata K, Taniguchi T, Liu FT, Ueno H.
    Exp Eye Res; 2006 Feb; 82(2):210-8. PubMed ID: 16102751
    [Abstract] [Full Text] [Related]

  • 2. Dissection of antigen-specific humoral and cellular immune responses for the development of experimental immune-mediated blepharoconjunctivitis in C57BL/6 mice.
    Fukushima A, Ozaki A, Jian Z, Ishida W, Fukata K, Ueno H, Liu FT.
    Curr Eye Res; 2005 Apr; 30(4):241-8. PubMed ID: 15823916
    [Abstract] [Full Text] [Related]

  • 3. Roles of OX40 in the development of murine experimental allergic conjunctivitis: exacerbation and attenuation by stimulation and blocking of OX40.
    Fukushima A, Yamaguchi T, Ishida W, Fukata K, Yagita H, Ueno H.
    Invest Ophthalmol Vis Sci; 2006 Feb; 47(2):657-63. PubMed ID: 16431965
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Endogenous interleukin-10 produced by antigen-irrelevant cells promotes the development of experimental murine allergic conjunctivitis.
    Fukushima A, Sumi T, Fukuda K, Kumagai N, Nishida T, Ueno H.
    Int Arch Allergy Immunol; 2007 Feb; 144(1):79-84. PubMed ID: 17505142
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Role of VLA-4 in the development of allergic conjunctivitis in mice.
    Fukushima A, Yamaguchi T, Ishida W, Fukata K, Ueno H.
    Mol Vis; 2006 Apr 07; 12():310-7. PubMed ID: 16617298
    [Abstract] [Full Text] [Related]

  • 8. Roles of galectin-9 in the development of experimental allergic conjunctivitis in mice.
    Fukushima A, Sumi T, Fukuda K, Kumagai N, Nishida T, Okumura K, Akiba H, Yagita H, Ueno H.
    Int Arch Allergy Immunol; 2008 Apr 07; 146(1):36-43. PubMed ID: 18087160
    [Abstract] [Full Text] [Related]

  • 9. Differential modulation of allergic eye disease by chronic and acute ascaris infection.
    Schopf L, Luccioli S, Bundoc V, Justice P, Chan CC, Wetzel BJ, Norris HH, Urban JF, Keane-Myers A.
    Invest Ophthalmol Vis Sci; 2005 Aug 07; 46(8):2772-80. PubMed ID: 16043850
    [Abstract] [Full Text] [Related]

  • 10. Cyclosporin A inhibits eosinophilic infiltration into the conjunctiva mediated by type IV allergic reactions.
    Fukushima A, Yamaguchi T, Ishida W, Fukata K, Liu FT, Ueno H.
    Clin Exp Ophthalmol; 2006 Aug 07; 34(4):347-53. PubMed ID: 16764655
    [Abstract] [Full Text] [Related]

  • 11. Modulation of murine experimental allergic conjunctivitis by treatment with alpha-galactosylceramide.
    Fukushima A, Sumi T, Fukuda K, Yamaguchi T, Kumagai N, Nishida T, Ueno H.
    Immunol Lett; 2006 Sep 15; 107(1):32-40. PubMed ID: 16930723
    [Abstract] [Full Text] [Related]

  • 12. Treatment with FTY720 during the induction or effector phase suppresses the development of experimental allergic conjunctivitis in mice.
    Sumi T, Fukushima A, Nishino K, Fukuda K, Kumagai N, Nishida T, Ueno H.
    Cell Biol Int; 2009 Apr 15; 33(4):534-41. PubMed ID: 19230848
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Regulatory T cells participate in 4-1BB-mediated suppression of experimental allergic conjunctivitis.
    Sumi T, Ishida W, Mittler RS, Yagita H, Taguchi O, Fukushima A.
    Int Arch Allergy Immunol; 2009 Apr 15; 148(4):305-10. PubMed ID: 19001790
    [Abstract] [Full Text] [Related]

  • 18. Oral and portal venous tolerance in the interferon-gamma knockout (GKO) mouse.
    Margenthaler JA, Kataoka M, Flye WM.
    J Surg Res; 2004 Jun 15; 119(2):107-12. PubMed ID: 15145690
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.